As in other cancers, several oncosuppressor genes are mutated in melanoma, including TP53 (tumor protein p53), NF1 (neurofibromin 1), CDKN2A and PTEN (phosphatase and tensin homolog), at a similar relatively low frequency (~15%) (Figure 1). This evidence concerns the gene CDKN2A and melanoma.